Used primarily as a key intermediate in the synthesis of selective androgen receptor modulators (SARMs), particularly in the development of investigational compounds aimed at treating muscle wasting conditions, osteoporosis, and other disorders related to androgen deficiency. Its structural configuration allows for high binding affinity to androgen receptors with tissue selectivity, making it valuable in pharmaceutical research. Due to its lipophilic nature imparted by the trifluoromethoxy and propyl groups, it enhances metabolic stability and oral bioavailability in drug candidates. It is not used in consumer products or industrial applications, and its handling is restricted to controlled laboratory and research settings.